Skip to content
Review

Inflammation as a central driver in AML pathogenesis and therapy resistance.

Oct 2026 · Science China Life Sciences · 0 citations · 212 references
Medicine

TL;DR

A deeper understanding of cell type-specific inflammatory circuits and cytokine interactions will be essential for developing rational combination therapies to overcome microenvironment-driven resistance.

View source

Similar papers

Review Open access Oct 2026

Malignant remodeling of the bone marrow microenvironment in acute myeloid leukemia: mechanisms and therapeutic implications

Acute myeloid leukemia (AML) is an aggressive clonal myeloid malignancy characterized by the expansion of differentiation-arrested blasts. Treatment resistance, measurable residual disease, and relapse remain major causes of treatment failure. Experimental and clinical evidence indicates that the bone marrow microenvir...

Wen-Hao Xu, Qing-Lian Han, Chang-Rong Sun et al. · 0 citations
Review Oct 2026

Therapy-Associated Myeloid Niches as Spatial Drivers of Cancer Treatment Resistance and Targets for Mechanism-Matched Intervention.

Tumor drug resistance is still the core obstacle limiting the long-term benefit of modern anticancer therapy, especially in the context of treatment tolerance, persistence of minimal residual disease (MRD) and recurrence after treatment. Increasing evidence has shown that therapy-associated myeloid niches can involve c...

Ting Li, Yan-Xia Lin, Q. Gang et al. · 0 citations
Review Open access Oct 2026

Dysregulation of the Bone Marrow Immune Microenvironment and Clinical Outcomes in Multiple Myeloma

The mechanisms underlying immune dysregulation in MM are discussed, recent discoveries regarding immune remodeling associated with clinical outcomes are summarized, and the translational implications of immune-based biomarkers and therapeutic strategies are explored.

Maria P. Ghirardi, Patrícia Brandalise, M. Berraondo et al. · 0 citations
Review Open access Sep 2026

Myeloid-derived suppressor cells in multiple myeloma: mechanistic insights and therapeutic implications

The mechanisms governing MDSCs interactions within the myeloma TME are elucidated, potential therapeutic strategies targeting MDSCs are discussed, and a rational framework for integrating MDSC-directed approaches with current MM therapies and immunotherapy is outlined.

Jing-Jing Wen, Qiao-Lin Zhou, Jing Yue et al. · 0 citations
Review Open access Oct 2026

TUMOR MICROENVIRONMENT: EMERGING INSIGHTS INTO CANCER PROGRESSION AND THERAPEUTIC TARGETS - A NARRATIVE REVIEW

The tumor microenvironment (TME) is increasingly recognized as a dynamic and biologically active ecosystem that profoundly influences cancer initiation, progression, metastasis, immune escape, and therapeutic resistance. Rather than functioning as an isolated mass of malignant cells, a tumor consists of complex interac...

Drishti Singla, Sahil Singhal, Samanvaya Sharma et al. · 0 citations
Oct 2026

Nanozyme-Powered Immunotherapy via Concurrent Niche Disruption and Checkpoint Blockade for Acute Myeloid Leukemia.

Acute myeloid leukemia (AML) relapse and drug resistance remain major causes of mortality in hematologic malignancies, driven in part by CXCR4/CXCL12-mediated homing and retention of leukemic cells within the bone marrow niche, as well as immune evasion mechanisms that enable their persistent survival. Here, we report...

Fei Wang, Qian-Qian Li, Yan Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.